Clinical profile of multisystem inflammatory syndrome in children associated with COVID-19 in a rural medical college
DOI:
https://doi.org/10.18203/2349-3291.ijcp20222416Keywords:
PIMS-TS, SARS CoV-2, Mortality, ArthritisAbstract
Background: Multisystem inflammatory syndrome in children (MIS-C) is a newly recognised syndrome temporally associated with SARS CoV-2 infections.
Methods: This was an observational both retrospective and prospective study in a rural medical college in eastern India. MIS‑C was diagnosed as per the criteria given by the WHO.
Results: First case of MIS-C of the institute was found in November 2020, maximum cases were seen during the second wave. There were 66 cases. Mortality was 6%. All presented with fever. There was swelling of joints in 56.6% cases, gastrointestinal symptoms in 65%, respiratory distress in (43.9%) and shock was present in 12.1% of cases in this study. Co-morbidities were present only in four cases (6%).
Conclusions: All cases of MIS-C had evidence of past infection with SARS CoV-2. There were relatively more cases of joint involvement and relatively less cases of shock in this study. The treatment using IVIG and methyl prednisolone was satisfactory. The 50% of the mortality was due to co-morbidities.
References
Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607-8.
Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P et al. PIMS-TS Study Group and EUCLIDS and PERFORM Consortia. Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA. 2020;324(3):259-69.
Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Multisystem inflammatory syndrome in US children and adolescents. N Engl J Med. 2020;383:334-46.
Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J et al. New York State and Centers for Disease Control and Prevention Multisystem Inflammatory Syndrome in Children Investigation Team. Multisystem Inflammatory Syndrome in Children in New York State. N Engl J Med. 2020;383(4):347-58
Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771-8.
Belhadjer Z, Méot M, Bajolle F, Khraiche D, Legendre A, Abakka S et al. Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in Context of Global SARS-CoV-2 Pandemic. Circulation. 2020;142(5):429-36.
Cabrero-Hernández M, García-Salido A, Leoz-Gordillo I, Alonso-Cadenas JA, Gochi-Valdovinos A, González Brabin A et al. Severe SARS-CoV-2 Infection in Children with Suspected Acute Abdomen: A Case Series From a Tertiary Hospital in Spain. Pediatr Infect Dis J. 2020;39(8):e195-8.
Dhanalakshmi K, Venkataraman A, Balasubramanian S, Madhusudan M, Amperayani S, Putilibai S et al. Epidemiological and Clinical Profile of Pediatric Inflammatory Multisystem Syndrome - Temporally Associated with SARS-CoV-2 (PIMS-TS) in Indian Children. Indian Pediatr. 2020;57(11):1010-14.
Royal College of Pediatrics and Child Health. Pediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS)-guidance for clinicians. 2020. Available at: https://www.rcpch.ac.uk/resources/paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19-pims-guidance. Accessed 5 March 2021.
World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19. 2020. Available at: https://www.who.int/publications/i/item/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19. Accessed on 12 March 2021.
Hoste L, Van Paemel R, Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: a systematic review. Eur J Pediatr. 2021;180(7):2019-34.
Giacalone M, Scheier E, Shavit I. Multisystem inflammatory syndrome in children (MIS-C): a mini-review. Int J Emerg Med. 2021;14(1):50.
Sethy G, Mishra B, Jain MK, Patnaik S, Mishra R, Behera JR et al. Clinical profile and immediate outcome of multisystem inflammatory syndrome in children associated with COVID-19: A multicentric study. J Global Infect Dis. 2021;13:159-63.
Awasthi P, Kumar V, Naganur S, Nallasamy K, Angurana SK, Bansal A et al. Multisystem Inflammatory Syndrome in Children: Follow-Up of a Cohort from North India. Am J Trop Med Hygiene. 2022;106(4):1108-12.
Nayak S, Panda PC, Biswal B, Agarwalla SK, Satapathy AK, Jena PK et al. and for EICOMISC Study Group Eastern India Collaboration on Multisystem Inflammatory Syndrome in Children (EICOMISC): A Multicenter Observational Study of 134 Cases. Front. Pediatr. 2022;10:834039.
Tiwari A, Balan S, Rauf A, Kappanayil M, Kesavan S, Raj M et al. COVID-19 related multisystem inflammatory syndrome in children (MIS-C): a hospital-based prospective cohort study from Kerala, India. BMJ Paediatrics Open. 2021;5:e001195.
Cavalcanti A, Islabão A, Magalhães C, Veloso S, Lopes M, do Prado R et al. Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): a Brazilian cohort. Adv Rheumatol. 2022;62(1):6.
Bagri NK, Deepak RK, Meena S, Gupta SK, Prakash S, Setlur K et al. Outcomes of multisystem inflammatory syndrome in children temporally related to COVID-19: a longitudinal study. Rheumatol Int. 2022;42:47784.
Jain S, Sen S, Lakshmivenkateshiah S, Bobhate P, Venkatesh S, Udani S et al. Multisystem Inflammatory Syndrome in Children With COVID-19 in Mumbai, India. Indian Pediatr. 2020;57(11):1015-9.
Maheshwari A, Mahto D, Kumar V, Gulati S, Pemde H, Saha A et al. Comparison of clinical and laboratory profile of survivors and non-survivors of SARS-CoV-2-related multisystem inflammatory syndrome of childhood in India: An observational study. J Paediatr Child Health. 2022;58(1):136-40.
Sugunan S, Bindusha S, Geetha S, Niyas HR, Kumar AS. Clinical Profile and Short-Term Outcome of Children With SARS-CoV-2 Related Multisystem Inflammatory Syndrome (MIS-C) Treated with Pulse Methylprednisolone. Indian Pediatr. 2021;58(8):718-22.
